Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Biodesix (BDSX) Gross Margin (2019 - 2025)

Biodesix (BDSX) has disclosed Gross Margin for 7 consecutive years, with 61.33% as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Gross Margin rose 791.0% year-over-year to 61.33%, compared with a TTM value of 81.11% through Dec 2025, up 517.0%, and an annual FY2025 reading of 81.11%, up 294.0% over the prior year.
  • Gross Margin was 61.33% for Q4 2025 at Biodesix, down from 91.97% in the prior quarter.
  • Across five years, Gross Margin topped out at 91.97% in Q3 2025 and bottomed at 36.89% in Q1 2021.
  • Average Gross Margin over 5 years is 69.02%, with a median of 66.44% recorded in 2022.
  • The sharpest move saw Gross Margin tumbled -3209bps in 2021, then surged 2327bps in 2022.
  • Year by year, Gross Margin stood at 65.49% in 2021, then increased by 0bps to 65.59% in 2022, then increased by 17bps to 77.0% in 2023, then crashed by -31bps to 53.42% in 2024, then increased by 15bps to 61.33% in 2025.
  • Business Quant data shows Gross Margin for BDSX at 61.33% in Q4 2025, 91.97% in Q3 2025, and 90.09% in Q2 2025.